Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Consolidated Statements of Cash Flows

v3.20.4
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Cash flows from operating activities      
Net loss $ (444,116) $ (11,079) $ (11,225)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:      
Goodwill impairment 386,154
Impairment of other long-lived assets 6,985 776 7,260
Depreciation and amortization 49,560 50,942 61,250
Stock-based compensation 20,204 20,564 15,686
Foreign currency transaction loss (gain) (8,718) (1,900) 5,140
Deferred income taxes (17,484) (2,393) (3,956)
Gain from sale of unconsolidated entity (3,578) (7,908)
Share in (profits) losses of associated companies 3,939 412 (1,724)
Other non-cash items (2,552) (103) 582
Change in cash, cash equivalents and restricted cash attributable to changes in operating assets and liabilities, net of the impact of acquisitions or divestitures:      
Accounts receivable, net 29,465 4,967 (8,884)
Inventories 37,120 (48,647) (16,124)
Net investment in sales-type leases 1,063 2,911 7,437
Other current assets and prepaid expenses 9,084 (5,847) 446
Other non-current assets (1,040) 5,807 (1,280)
Accounts payable (24,534) (13,114) 6,882
Other current liabilities (10,033) (7,273) 9,183
Deferred revenues (6,398) (3,779) 6,203
Other non-current liabilities (897) 141 (5,256)
Net cash provided by (used in) operating activities 27,802 (11,193) 63,712
Cash flows from investing activities      
Purchase of property and equipment (26,943) (22,549) (23,361)
Acquisition of business, net of cash acquired (29,115)
Proceeds from sale of subsidiaries and unconsolidated entity 4,909 41,168
Investment in unconsolidated entities (20,222) (13,015)
Proceeds from sale of plant and property 129 4,105
Purchase of intangible assets (2,070) (2,752) (1,449)
Investments in short-term bank deposits (27,000) (28,300)
Proceeds from short-term bank deposits 28,300
Proceeds from sale of equity method investment 3,175
Net proceeds from divestitures of subsidiaries and associated companies 1,000
Other investing activities 28 (741) (304)
Net cash provided by (used in) investing activities (52,625) (69,526) 7,144
Cash flows from financing activities      
Repayment of debt (27,293) (5,143)
Acquisition of redeemable non-controlling interests   (1,500)
Proceeds from exercise of stock options 228 5,284 3,692
Net cash provided by (used in) financing activities 228 (22,009) (2,951)
Effect of exchange rate changes on cash, cash equivalents and restricted cash 3,214 2,591 (3,530)
Net change in cash, cash equivalents and restricted cash (21,381) (100,137) 64,375
Cash, cash equivalents and restricted cash, beginning of year 293,597 393,734 329,359
Cash, cash equivalents and restricted cash, end of year 272,216 293,597 393,734
Cash paid during the year for:      
Income taxes, net of tax refunds 1,140 10,730 5,682
Interest 449 1,675
Non-cash investing activities:      
Transfer of inventories to fixed assets 4,138 3,307 3,702
Transfer of fixed assets to inventories 410 322 451
Origin contingent consideration 37,400
Issuance of shares as part of Origin acquisition (Refer to Note 2) $ 26,636